Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Tirzepatide

SURMOUNT-CN

Eli Lilly · Phase 3 · Completed · Enrollment 210

NCT05024032

ArmPopulationDoseWeeksEstimandWeight change
10 Milligrams (mg) TirzepatideObesity or overweightn/rn/rn/rn/r
15 mg TirzepatideObesity or overweight15 mg52n/rn/r
PlaceboObesity or overweightn/r52n/rn/r
10 mg TirzepatideObesity or overweight10 mg52n/rn/r